Diabetes dog symptoms chronic disease management
Learn about the symptoms of canine diabetes and how to manage the disease.
Keresés
Jardiance®
Treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
Cardiometabolic Research
Read about our patient-centric approach to cardiometabolic disease research.
Glyxambi®
Treatment of type 2 diabetes mellitus to improve glycaemic control in adults when treatment with both empagliflozin and linagliptin is appropriate (US).
Trajenta®
Treatment of type 2 diabetes mellitus to improve glycaemic control in adults, used in monotherapy (if metformin is not tolerated or contraindicated) or in combination therapy.
Synjardy®
Treatment of type 2 diabetes mellitus to improve glycaemic control in adults when treatment with metformin does not lead to sufficient control or when patients are treated with jardiance® (empagliflozin) and metformin.
Jentadueto®
Treatment of type 2 diabetes mellitus to improve glycaemic control in adults when treatment with metformin does not lead to sufficient control or when patients are treated with trajenta® (linagliptin) and metformin.
Micardis®
Treatment of hypertension. For the reduction of the risk of myocardial infarction (heart attack), stroke or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take A
Ingelvac CircoFLEX
For the active immunisation of pigs over the age of two weeks against porcine circovirus type 2 to reduce mortality, clinical signs – including weight loss – and lesions in lymphoid tissues associated with porcine circovirus diseases (PCVD).
Életmenő ötlet abbahagyni
Életmenő ötlet abbahagyni - a dohányzásról való leszokást követően szervezetünk regenerálódik -
ProZinc
Protamine Zinc
Életmenő ötlet abbahagyni
Életmenő ötlet abbahagyni
Taking Cancer On: The Podcast
From early stage discovery to clinical trials and approval, we’re Taking Cancer On.
Advice to Fellow Patients
People living with cancer share their advice for fellow patients, from checking information sources to living in the present moment.
Win Fight Against Cancer
At Boehringer Ingelheim we are giving patients new hope. We are collaborating with the oncology community on a shared journey to deliver leading science.
LUX-Lung 7 & 8 Trials
.
Introduction to head-to-head trials
Introduction to head-to-head trials Hear from experts Dr Kerr and Dr Melosky.
More Cherished Moments
Innovation in healthcare is about more than just a new approach or technology. We innovate for better health of people and animals.
History video
Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim
Four Pillars Cancer Immunology
Boehringer Ingelheim is focusing cancer immunology research on T cell engagers, cancer vaccines, oncolytic viruses and immune & stromal modulation
A Unique Bond: friends in need
After suffering from a stroke, Phil’s connection with Valle helped change his life
Mental Health
Hear the perspectives of people living with cancer on the topic of mental health.
Drug Discovery Process
Drug Discovery Process From initial discovery to a marketable medicine is a long, challenging road. It takes about 12 - 15 years from discovery to the approved medication and requires an investment of about US $1 billion. On average, from more than a mill
100-year anniversary of BI in respiratory care
100-year anniversary of Boehringer Ingelheim in respiratory care
The Neuroscience Gallery
Take a guided tour through our virtual 3-D Neuroscience art exhibition, with Clinical Program Leader, Dr. Michael Sand.